Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Apr;46(4):431-440.
doi: 10.1002/clc.24000. Epub 2023 Feb 23.

Long-term outcomes after stent implantation in very small vessel coronary artery disease

Affiliations
Observational Study

Long-term outcomes after stent implantation in very small vessel coronary artery disease

En-Shao Liu et al. Clin Cardiol. 2023 Apr.

Abstract

Background: Percutaneous coronary interventions (PCI) in very small vessel lesions represent an intriguing aspect of coronary artery disease (CAD). Uncertainty still exists in stent implantation in very small caliber vessels. This study aimed to evaluate the long-term outcomes of patients treated with 2.0-mm drug-eluting stent (DES).

Method: This retrospective observational study included 134 patients undergoing PCI with 2.0-mm zotarolimus DES from December 2016 to May 2020. The primary endpoint was major adverse cardiovascular events (MACE) at 2-year follow-up, which was composed of all-cause mortality, target vessel myocardial infarction, and ischemia-driven target lesion revascularization. Multiple logistic regression analysis was used to identify the independent predictors of MACE, and odds ratios (OR) and 95% confidence intervals (CI) were calculated.

Result: The lesions were diffuse (mean length 20.9 ± 5.51 mm) and belong to type B2/C lesions (90.3%). On follow-up, the MACE rate was 20.1% and mostly driven by late lumen loss demanding revascularization (11.9%). In multivariable analysis, chronic kidney disease (CKD) (OR: 4.291, 95% CI: 1.574-11.704, p = 0.004) and calcified lesions (OR: 3.688, 95% CI: 1.311-10.371, p = 0.013) were the independent predictors of subsequent cardiovascular events, whereas statin was associated with better outcomes (OR: 0.335, 95% CI: 0.119-0.949, p = 0.040).

Conclusion: 2.0-mm DES is a feasible option for treating very small vessel CAD in complex lesions. Patients with CKD and calcified lesions carry the hazard of worse outcomes, and careful consideration should be taken before stenting in this high-risk population.

Keywords: chronic kidney disease; drug-eluting stent; percutaneous Coronary intervention; very small vessel coronary artery disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Biondi‐Zoccai GG, Sangiorgi GM, Antoniucci D, et al. Testing prospectively the effectiveness and safety of paclitaxel‐eluting stents in over 1000 very high‐risk patients: design, baseline characteristics, procedural data and in‐hospital outcomes of the multicenter taxus in real‐life usage evaluation (TRUE) study. Int J Cardiol. 2007;117(3):349‐354. - PubMed
    1. Scholz SS, Lauder L, Ewen S, et al. One‐year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry. Clin Res Cardiol. 2020;109(7):845‐856. - PMC - PubMed
    1. Elezi S, Kastrati A, Neumann F‐J, Hadamitzky M, Dirschinger J, Schömig A. Vessel size and long‐term outcome after coronary stent placement. Circulation. 1998;98(18):1875‐1880. - PubMed
    1. Garg S, Serruys PW. Coronary stents: current status. J Am Coll Cardiol. 2010;56(suppl 10):S1‐S42. - PubMed
    1. van der Heijden LC, Kok MM, Danse PW, et al. Small‐vessel treatment with contemporary newer‐generation drug‐eluting coronary stents in all‐comers: insights from 2‐year Dutch PEERS (TWENTE II) randomized trial. Am Heart J. 2016;176:28‐35. - PubMed

Publication types